好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Retinal Microvascular Changes Differentiate Mild Stroke and Transient Ischemic Attack (TIA) from Mimics among Patients Presenting to the Emergency Department (ED) with Suspected TIA: The FOTO-TIA Study
Cerebrovascular Disease and Interventional Neurology
S26 - Cerebrovascular Disease: Systems of Stroke Care (2:48 PM-3:00 PM)
010
A primary aim of the FOTO-TIA study was to investigate a possible role for retinal microvascular findings in TIA risk stratification.
About 10% of the 250–500,000 Americans who experience TIA annually have a stroke within 90 days. Clinical scores and MRI-DWI findings are routinely used to help triage patients with suspected TIA, although categorizing DWI-negative spells as TIAs or non–cerebrovascular events (CVE) is challenging.

FOTO-TIA was a cohort study of adult patients with a NIH Stroke Scale ≤ 3 admitted to three EDs’ observation units for an accelerated diagnostic protocol for suspected TIA or stroke. Clinical and imaging results were recorded prospectively. Non-mydriatic fundus photographs were obtained as part of the accelerated diagnostic protocol and reviewed for retinal microvascular findings, defined as retinal hemorrhages, cotton wool spots, retinal emboli or occlusions, hard exudates, or microaneurysms. A neurologist rated the probability each patient’s presentation (masked to fundus photography) represented a CVE on a visual analogue scale.

395 patients were enrolled (median age: 57 years (interquartile range [IQR]: 50–66); 219 (55%) women; 253 (64%) black; 34 (9%) retinal microvascular findings present; median CVE probability assessment 22% (IQR: 5–100)). Controlling for the individual components of the ABCD2 score (age, systolic and diastolic blood pressure, clinical symptoms, duration of symptoms, and diabetes) and presence of a MRI-DWI positive lesion, any retinal microvascular finding increased the CVE probability assessment by 15.6% (95%CI: 4.2–27.1%, p=0.008). Excluding patients with a DWI positive lesion (i.e., those with definite stroke), any retinal microvascular finding increased CVE probability assessment by 21.8% (95%CI: 6.1–37.5%, p=0.007).

Retinal microvascular findings assessed by nonmydriatic ocular fundus photographs during the evaluation of suspected TIAs in the ED are an independent factor differentiating TIA and stroke from mimics.

Authors/Disclosures
Beau B. Bruce, MD, FAAN (Centers for Disease Control & Prevention)
PRESENTER
Dr. Bruce has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Bayer.
No disclosure on file
Fadi B. Nahab, MD Dr. Nahab has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Legal Consultation. Dr. Nahab has received intellectual property interests from a discovery or technology relating to health care.
No disclosure on file
Nicolas A. Bianchi, MD (Emory University) Dr. Bianchi has received personal compensation in the range of $0-$499 for serving as a Consultant for Innovation Hub Enterprises, LLC. The institution of Dr. Bianchi has received research support from Emory Medical Care Foundation.
No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file
Valerie Biousse, MD Dr. Biousse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gensights Biologic. Dr. Biousse has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Topcon. Dr. Biousse has received publishing royalties from a publication relating to health care. Dr. Biousse has received publishing royalties from a publication relating to health care.
Nancy J. Newman, MD, FAAN (Emory University School of Medicine) Dr. Newman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for GenSight. Dr. Newman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Chiesi. Dr. Newman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stoke. Dr. Newman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurophth. Dr. Newman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. The institution of Dr. Newman has received research support from GenSight. The institution of Dr. Newman has received research support from Santhera. The institution of Dr. Newman has received research support from NINDS/NIH. Dr. Newman has received publishing royalties from a publication relating to health care. Dr. Newman has received publishing royalties from a publication relating to health care. Dr. Newman has received publishing royalties from a publication relating to health care.